These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3580445)

  • 21. [Genetic polymorphism of acetylation and hydroxylation in the Briton population].
    Bressollette L; Berthou F; Riche C; Mottier D; Floch HH
    Therapie; 1990; 45(2):99-103. PubMed ID: 2353336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A unique pharmacogenetic expression of the N-acetylation polymorphism in the inbred hamster.
    Hein DW; Omichinski JG; Brewer JA; Weber WW
    J Pharmacol Exp Ther; 1982 Jan; 220(1):8-15. PubMed ID: 7053425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical consequences of acetylation polymorphism].
    Jendryczko A; Gmiński J
    Pol Tyg Lek; 1984 Sep; 39(37):1249-52. PubMed ID: 6150471
    [No Abstract]   [Full Text] [Related]  

  • 24. Construction of Syrian hamster lines congenic at the polymorphic acetyltransferase locus (NAT2): acetylator genotype-dependent N- and O-acetylation of arylamine carcinogens.
    Hein DW; Doll MA; Rustan TD; Gray K; Ferguson RJ; Feng Y
    Toxicol Appl Pharmacol; 1994 Jan; 124(1):16-24. PubMed ID: 8291057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An assessment of acetylator polymorphism and its relevance in Papua New Guinea.
    Hombhanje F
    P N G Med J; 1990 Jun; 33(2):107-10. PubMed ID: 2238823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetylator genotype-dependent formation of 2-aminofluorene-hemoglobin adducts in rapid and slow acetylator Syrian hamsters congenic at the NAT2 locus.
    Feng Y; Rustan TD; Ferguson RJ; Doll MA; Hein DW
    Toxicol Appl Pharmacol; 1994 Jan; 124(1):10-5. PubMed ID: 8291051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark.
    Lower GM; Nilsson T; Nelson CE; Wolf H; Gamsky TE; Bryan GT
    Environ Health Perspect; 1979 Apr; 29():71-9. PubMed ID: 510245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms.
    Potter JD; Bigler J; Fosdick L; Bostick RM; Kampman E; Chen C; Louis TA; Grambsch P
    Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):69-75. PubMed ID: 9950242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-acetylation pharmacogenetics.
    Weber WW; Hein DW
    Pharmacol Rev; 1985 Mar; 37(1):25-79. PubMed ID: 2860675
    [No Abstract]   [Full Text] [Related]  

  • 30. Acetylator phenotypes: allele frequency in northwestern Argentina and review of acetylator distribution in the Americas.
    Dipierri JE; Alfaro E; Bejarano IF; Etchart AA
    Hum Biol; 1998 Oct; 70(5):959-64. PubMed ID: 9780522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetylator phenotype in patients with allergic diseases and its clinical significance.
    Orzechowska-Juzwenko K; Milejski P; Patkowski J; Nittner-Marszalska M; Malolepszy J
    Int J Clin Pharmacol Ther Toxicol; 1990 Oct; 28(10):420-5. PubMed ID: 2258251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acetylator phenotype in spondylarthritis ankylopoietica].
    Rojkovich B; Genti G; Borbás E; Bálint G; Gömör B
    Orv Hetil; 1989 Dec; 130(49):2639-41. PubMed ID: 2689951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High frequency of the rapid isoniazid acetylator phenotype in Lagos (Nigeria).
    Odeigah PG; Okunowo MA
    Hum Hered; 1989; 39(1):26-31. PubMed ID: 2759621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetylator polymorphism in human colorectal carcinoma.
    Ladero JM; González JF; Benítez J; Vargas E; Fernández MJ; Baki W; Diaz-Rubio M
    Cancer Res; 1991 Apr; 51(8):2098-100. PubMed ID: 2009528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isoniazid acetylator phenotype.
    Raghupati Sarma G
    Indian Pediatr; 1989 Feb; 26(2):197-8. PubMed ID: 2753546
    [No Abstract]   [Full Text] [Related]  

  • 36. [Determination of the phenotype of N-acetyltransferase activity].
    Bulovskaia LN; Borisenko GN; Drobachenko OA; Kurbatova GP; Ivanova VV
    Lab Delo; 1990; (10):28-30. PubMed ID: 1704451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A simplified and rapid test for acetylator phenotyping by use of the peak height ratio of two urinary caffeine metabolites.
    el-Yazigi A; Chaleby K; Martin CR
    Clin Chem; 1989 May; 35(5):848-51. PubMed ID: 2566399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acetylation polymorphism and leprosy.
    Eze LC; Okpogba AN; Ogan AU
    Biochem Genet; 1990 Feb; 28(1-2):1-7. PubMed ID: 2344344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antitubercular agents: pharmacogenetic factors in the development of adverse effects].
    Ligueros M; Saavedra H; Neira S; Cruz-Coke R; Saavedra A; Kramer V; Gelman M; Nuñez A; Prieto JC
    Rev Med Chil; 1990 Jul; 118(7):727-35. PubMed ID: 2131519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inherited defects of hepatic drug metabolism.
    Küpfer A; Preisig R
    Semin Liver Dis; 1983 Nov; 3(4):341-54. PubMed ID: 6417793
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.